EBOS Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EBOSY research report →
About the company
EBOS Group Limited, established in 1922 and headquartered in Docklands, Australia, operates as a prominent marketer, wholesaler, and distributor of a broad spectrum of healthcare, medical, pharmaceutical, and animal care products. Its operations span Australia, New Zealand, and Southeast Asia, structured primarily around its Healthcare and Animal Care divisions. The Healthcare segment offers a comprehensive suite of services and products.
- CEO
- Adam Luke Hall
- IPO
- 2017
- Employees
- 5,200
- HQ
- Docklands, VIC, AU
Price Chart
- Market Cap
- $1.33B
- P/E
- 16.92
- P/S
- 0.25
- P/B
- 1.34
- EV/EBITDA
- 11.36
- Div Yield
- 5.77%
- Gross Margin
- 10.29%
- Op Margin
- 2.45%
- Net Margin
- 1.43%
- ROE
- 8.16%
- ROIC
- 5.59%
- Revenue
- $12.20B · -7.23%
- Net Income
- $213.89M · -20.98%
- EPS
- $4.36 · -22.70%
- Op Income
- $420.65M
- FCF YoY
- 47.82%
- 52W High
- $46.64
- 52W Low
- $24.13
- 50D MA
- $26.08
- 200D MA
- $33.69
- Beta
- 0.16
- Avg Volume
- 89
Get TickerSpark's AI analysis on EBOSY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EBOSY coverage
Recent articles, reports, and earnings notes.
No research on EBOSY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EBOSY report →Similar companies
Peers in the same neighborhood.